Progesterone micronised 200mg capsules (Gepretix®) added to the HRT PPC medicines list from April 2025
From 1 April 2025, Progesterone micronised 200mg capsules (Gepretix®) has been added to the list of medicines covered by the HRT prepayment certificate (HRT PPC).
This change has been reflected in Part XVI of the April 2025 Drug Tariff and on the NHSBSA’s website.
Community Pharmacy England has also updated its HRT medicines list to reflect the changes taking effect from April 2025. Please note: you may need to hard refresh (press Ctrl+R) to refer to the most up-to-date version.
The HRT medicines list has been compiled following consultation with the Medicines and Healthcare products Regulatory Agency (MHRA), NHSBSA and the NHS England Menopause Clinical Reference Group. The list will be updated as new HRT medicines licensed for the treatment of menopause become available in the UK or as existing HRT medicines are discontinued from the UK market. If a product that meets the criteria is missing from the HRT medicines list please contact dhsc.publicenquiries@dhsc.gov.uk.
Patients who normally pay for their prescriptions and are prescribed eligible HRT medicines 3 or more times in 12 months could save money with a HRT PPC.
